Boston Scientific (BSX) Revenue — Quarter Ended Mar 31, 2025
Revenue for the reporting quarter increased compared with both the preceding quarter and the same period a year earlier. The growth rate relative to the prior year, while still strong, was slightly lower than the rate seen in the preceding quarter.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the reporting quarter increased compared with both the preceding quarter and the same period a year earlier. The growth rate relative to the prior year, while still strong, was slightly lower than the rate seen in the preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$4.7B
Revenue reported for this quarter.
Quarter-over-quarter
+2.2%
Change from the immediately preceding quarter.
Year-over-year
+20.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$17.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $4.1B | +14.5% |
| Sep 30, 2024 | $4.2B | +19.3% |
| Dec 31, 2024 | $4.6B | +22.4% |
| Mar 31, 2025 | $4.7B | +20.9% |
Revenue performance
The company reported higher revenue for the quarter, driven by continued expansion across its business segments.
Quarterly comparison
Sequentially, revenue rose from the immediately preceding quarter. On a year-over-year basis, revenue also increased, though the pace of annual growth moderated compared to the prior quarter.
What to watch
The moderation in the year-over-year growth rate relative to the preceding quarter bears watching.